Food and drug regulatory issues

Area of Science:

• Veterinary Pharmacology
• Regulatory Science

Background:

• The Federal Food, Drug, and Cosmetic Act governs drug usage in veterinary medicine.
• Current regulations restrict veterinarians from using drugs in extralabel ways or using human drugs for animal treatment.
• These restrictions do not fully meet the needs of the veterinary profession.

Purpose of the Study:

• To examine the regulatory landscape of drug use in veterinary medicine.
• To discuss the implications of the Federal Food, Drug, and Cosmetic Act on veterinary practice.
• To review the Food and Drug Administration's (FDA) policy of discretionary enforcement regarding extralabel drug use.

Main Methods:

• Analysis of the Federal Food, Drug, and Cosmetic Act and its impact on veterinary drug use.
• Review of the FDA's current enforcement policies and their application to veterinary medicine.
• Examination of ongoing efforts to amend the Act to permit extralabel drug use.

Main Results:

• The Act prohibits extralabel drug use, use of human drugs in animals, and drug compounding by veterinarians.
• The FDA employs discretionary enforcement, allowing extralabel use for companion, exotic, and sporting animals while focusing on food-producing animals for residue concerns.
• Proposed amendments aim to legalize extralabel drug use rather than relying solely on enforcement discretion.

Conclusions:

• The current Act presents limitations for practicing veterinarians regarding drug use.
• FDA's discretionary enforcement provides some flexibility but highlights the need for legislative reform.
• Amendments to the Act are crucial for better aligning drug regulations with the practical needs of veterinary medicine.